Skip to content
thispeptide

Pick what you want to change.

Sellers we have reviewed

The licensed telehealths we have written a review of, and which of the prescribable peptides above each one lists. Each goal page narrows this to the sellers for that goal.

Disclosure: This Peptide is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.

  1. Bayan Health
    PrescribesSemaglutide,Tirzepatide,Orforglipron,Sermorelin,NAD+,Glutathione,GHK-Cu,PT-141 (bremelanotide)WeightSexual healthLongevityRecoverySleep
  2. Kin Meds
    PrescribesSemaglutide,Tirzepatide,Orforglipron,Sermorelin,NAD+,Glutathione,GHK-Cu,PT-141 (bremelanotide)WeightSexual healthLongevityRecoverySleep
  3. Wellspring Longevity Clinic
    PrescribesSemaglutide,Tirzepatide,Orforglipron,Sermorelin,NAD+,Glutathione,GHK-Cu,PT-141 (bremelanotide)WeightSexual healthLongevityRecoverySleep
  4. AgelessRx
    PrescribesSemaglutide,Tirzepatide,Sermorelin,NAD+,Glutathione,GHK-Cu,PT-141 (bremelanotide)WeightSexual healthLongevityRecoverySleep

Ordered by how many of these peptides each seller prescribes, then by name. A partnership never changes the order.

See all 453 seller reviews →

Latest research

All research →
  1. Every goalCompounded Semaglutide Dosing Errors: Where Confusion StartsConcentration, milligrams, milliliters and syringe markings can be confused. FDA reports show why instructions must match the specific vial and syringe.Read it →
  2. Every goalHow to Report Peptide Side Effects: MedWatch and the Details to SaveGet care first, then preserve the label, lot number and timeline. A suspected reaction can be reported without proving that the medicine caused it.Read it →
  3. Every goalPeptide Blends Safety: Does Combining Ingredients Improve the Evidence?A blend needs evidence for its ingredients, combination and route. Familiar ingredients and a laboratory purity result cannot establish all three.Read it →
  4. Every goalPeptide Clinical Trials: How to Check What a Study Actually TestsA trial listing can help you find legitimate research. Learn to read recruitment status, eligibility, endpoints and posted results without treating registration as proof.Read it →
  5. Every goalPeptide Vial Beyond Use Date: The Label and the First-Puncture ClockA beyond-use date and an opened-vial limit are different. FDA now advises discarding compounded GLP-1 multidose vials within 28 days after first use.Read it →
  6. Every goalSemaglutide Sodium vs Base: Why the Ingredient MattersFDA distinguishes semaglutide base from sodium and acetate salts. Here is what a label can establish, what a purity claim cannot, and what to ask the pharmacy.Read it →

What we list, and what we will not.

Our prescribing comparisons cover approved products and potentially eligible compounded preparations.11 of the 30 peptides we track fall within those categories. Compounding depends on applicable federal and state requirements and prescription conditions. Tesamorelin and SS-31 count only as brand-name drugs, approved for a use no goal here covers. Coverage here is limited to those approved products, so we link no unverified seller. This coverage limit is not a determination of compounding legality. The other 19 we cover as research, with no seller linked.

Each status is read from the FDA’s own documents, such as its list of substances nominated for compounding, and every goal page names the source for every peptide on it. We track 601 telehealth sellers.

Frequently asked questions

Which peptides can a licensed telehealth prescribe?
11 of the 30 peptides we track have an FDA-approved product or a potentially eligible compounded preparation: Semaglutide, Tirzepatide, Liraglutide, Orforglipron, Sermorelin, NAD+, Glutathione, GHK-Cu, PT-141 (bremelanotide), Tesamorelin and SS-31. Compounding depends on applicable federal and state requirements and prescription conditions. Tesamorelin and SS-31 count only as brand-name drugs, approved for a use no goal here covers. Coverage here is limited to those approved products, so we link no unverified seller. This coverage limit is not a determination of compounding legality.
Why do some peptides here have no seller?
19 of the 30 peptides we track (MOTS-c, BPC-157, Kisspeptin, CJC-1295, Ipamorelin, Epitalon, DSIP, TB-500, Retatrutide, MK-677, Thymosin alpha-1, Oxytocin, KPV, Melanotan II, AOD-9604, Semax, Selank, LL-37 and 5-Amino-1MQ) have no FDA approval, and no FDA list we have read allows them to be compounded. We cover the research on each one and link no seller for any of them.
How many telehealth sellers do you cover?
We track 601 telehealth sellers and have published a review of 453. A seller is ranked on a best-of board only after we review it, and a board is published only when at least 3 reviewed sellers fit it. 12 boards clear that bar today.
Do sellers pay to be listed?
We have affiliate partnerships with some of the sellers we cover, but not all of them. A partner pays us a commission when you buy through its link, and it cannot pay for a review or a better score: the score comes from a published rubric that does not read who pays us. On the best-of boards, partners are listed first and labeled Partner.
Where does your research come from?
Our 165 research articles cite 1,235 sources between them. 758 are papers indexed on PubMed and 326 are FDA documents or drug labels. Each article lists its sources at the end.